2024 Q4 Form 10-Q Financial Statement

#000149315224044515 Filed on November 12, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3 2023 Q3
Revenue $669.4K $0.00
YoY Change
Cost Of Revenue $191.9K
YoY Change
Gross Profit $477.5K
YoY Change
Gross Profit Margin 71.34%
Selling, General & Admin $42.98K $48.99K
YoY Change -12.26% 1980.3%
% of Gross Profit 9.0%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $5.998K $1.298K
YoY Change 362.1% 0.0%
% of Gross Profit 1.26%
Operating Expenses $210.9K $325.3K
YoY Change -35.17% -4.05%
Operating Profit $266.6K -$325.3K
YoY Change -181.97% -4.05%
Interest Expense -$10.10K $1.550M
YoY Change -100.65% 454.48%
% of Operating Profit -3.79%
Other Income/Expense, Net -$10.10K $1.550M
YoY Change -100.65% 454.47%
Pretax Income $256.5K $1.225M
YoY Change -79.05% -2160.05%
Income Tax
% Of Pretax Income
Net Earnings $256.5K $1.225M
YoY Change -79.05% -2160.05%
Net Earnings / Revenue 38.32%
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 14.69B shares 14.69B shares
Diluted Shares Outstanding 14.69B shares 14.54B shares

Balance Sheet

Concept 2024 Q4 2024 Q3 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $292.9K $13.19K
YoY Change 2120.32% 261.37%
Cash & Equivalents $292.9K $13.19K
Short-Term Investments
Other Short-Term Assets $225.0K
YoY Change
Inventory
Prepaid Expenses $225.0K
Receivables $156.6K
Other Receivables $0.00
Total Short-Term Assets $674.5K $13.19K
YoY Change 5013.5% -65.25%
LONG-TERM ASSETS
Property, Plant & Equipment $120.6K $16.45K
YoY Change 633.01% -23.99%
Goodwill $7.686M $2.890M
YoY Change 165.94%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $7.831M $6.506M
YoY Change 20.36% 1650.71%
Total Long-Term Assets $7.831M $6.506M
YoY Change 20.36% 1650.71%
TOTAL ASSETS
Total Short-Term Assets $674.5K $13.19K
Total Long-Term Assets $7.831M $6.506M
Total Assets $8.506M $6.520M
YoY Change 30.46% 1491.69%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $50.35K $10.42K
YoY Change 383.05% -66.85%
Accrued Expenses $110.9K $114.6K
YoY Change -3.2% 120.56%
Deferred Revenue
YoY Change
Short-Term Debt $463.3K $3.590M
YoY Change -87.1% 1087.72%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $6.717M $6.673M
YoY Change 0.65% 472.47%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $6.717M $6.673M
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $6.717M $6.673M
YoY Change 0.65% 472.47%
SHAREHOLDERS EQUITY
Retained Earnings -$166.4M -$166.3M
YoY Change 0.09% -0.15%
Common Stock $162.9M $161.5M
YoY Change 0.89% -1.76%
Preferred Stock $1.861M $1.702M
YoY Change 9.33% 22.9%
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.789M -$3.053M
YoY Change
Total Liabilities & Shareholders Equity $8.506M $6.520M
YoY Change 30.46% 1491.69%

Cashflow Statement

Concept 2024 Q4 2024 Q3 2023 Q3
OPERATING ACTIVITIES
Net Income $256.5K $1.225M
YoY Change -79.05% -2160.05%
Depreciation, Depletion And Amortization $5.998K $1.298K
YoY Change 362.1% 0.0%
Cash From Operating Activities $217.1K -$102.7K
YoY Change -311.35% -67.98%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$40.00K $97.62K
YoY Change -140.98%
NET CHANGE
Cash From Operating Activities $217.1K -$102.7K
Cash From Investing Activities
Cash From Financing Activities -$40.00K $97.62K
Net Change In Cash $177.1K -$5.110K
YoY Change -3566.03% -98.41%
FREE CASH FLOW
Cash From Operating Activities $217.1K -$102.7K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q3 dei Entity Central Index Key
EntityCentralIndexKey
0000932021
CY2024Q3 dei Document Type
DocumentType
10-Q
CY2024Q3 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2024Q3 dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
CY2024Q3 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024Q3 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024Q3 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2024Q3 dei Entity Small Business
EntitySmallBusiness
true
CY2024Q3 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2024Q3 dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 dei Security12b Title
Security12bTitle
Common Stock
CY2024Q3 dei Trading Symbol
TradingSymbol
GTLL
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
14688440097 shares
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
292861 usd
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
115747 usd
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
156610 usd
CY2024Q3 us-gaap Goodwill
Goodwill
7685636 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
25000 usd
CY2024Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
7831245 usd
CY2024Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
7837243 usd
CY2024Q3 us-gaap Assets
Assets
8505716 usd
CY2024Q2 us-gaap Assets
Assets
8362682 usd
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
50348 usd
CY2024Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
90785 usd
CY2024Q3 us-gaap Interest Payable Current
InterestPayableCurrent
95745 usd
CY2024Q2 us-gaap Interest Payable Current
InterestPayableCurrent
85650 usd
CY2024Q3 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
15160 usd
CY2024Q3 GTLL Notes Payable Third Parties Current
NotesPayableThirdPartiesCurrent
395000 usd
CY2024Q2 GTLL Notes Payable Third Parties Current
NotesPayableThirdPartiesCurrent
435000 usd
CY2024Q2 us-gaap Loans Payable Current
LoansPayableCurrent
68269 usd
CY2024Q3 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
5764227 usd
CY2024Q3 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
327947 usd
CY2024Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
327947 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
6716696 usd
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
6830211 usd
CY2024Q3 us-gaap Liabilities
Liabilities
6716696 usd
CY2024Q2 us-gaap Liabilities
Liabilities
6830211 usd
CY2024Q3 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
CY2024Q3 dei Entity File Number
EntityFileNumber
000-25668
CY2024Q3 dei Entity Registrant Name
EntityRegistrantName
GLOBAL TECHNOLOGIES, LTD
CY2024Q3 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2024Q3 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
86-0970492
CY2024Q3 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 105
CY2024Q3 dei Entity Address City Or Town
EntityAddressCityOrTown
Parsippany
CY2024Q3 dei Entity Address State Or Province
EntityAddressStateOrProvince
NJ
CY2024Q3 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
07054
CY2024Q3 dei City Area Code
CityAreaCode
(973)
CY2024Q3 dei Local Phone Number
LocalPhoneNumber
233-5151
CY2024Q3 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2024Q3 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2025
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
usd
CY2023Q3 us-gaap Cost Of Revenue
CostOfRevenue
usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
usd
CY2024Q3 GTLL Consulting Services
ConsultingServices
usd
CY2023Q3 us-gaap Professional Fees
ProfessionalFees
usd
CY2024Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
usd
CY2024Q3 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023Q3 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
usd
CY2024Q3 us-gaap Amortization Of Acquisition Costs
AmortizationOfAcquisitionCosts
usd
CY2024Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
usd
CY2024Q3 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
usd
CY2024Q3 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
usd
CY2023Q3 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
usd
CY2024Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
CY2023Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
CY2023Q3 GTLL Payments On Convertible Notes Payable
PaymentsOnConvertibleNotesPayable
usd
CY2024Q3 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
usd
CY2024Q3 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
usd
CY2024Q3 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2023Q3 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2024Q3 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2023Q3 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2024Q3 GTLL Issuance Of Common Stock For Debt
IssuanceOfCommonStockForDebt
usd
CY2023Q3 GTLL Issuance Of Common Stock For Debt
IssuanceOfCommonStockForDebt
usd
CY2024Q3 GTLL Accrual For Contingent Consideration Of Acquisition Of Foxx Trott Tango Llc
AccrualForContingentConsiderationOfAcquisitionOfFoxxTrottTangoLlc
usd
CY2023Q3 us-gaap Revenues
Revenues
usd
CY2024Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
usd
CY2024Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
usd
CY2024Q3 dei Document Transition Report
DocumentTransitionReport
false
CY2024Q3 dei Entity Address Address Line1
EntityAddressAddressLine1
8 Campus Drive
CY2024Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
184692 usd
CY2024Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
225000 usd
CY2024Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
225000 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
674471 usd
CY2024Q2 us-gaap Assets Current
AssetsCurrent
525439 usd
CY2024Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
40754 usd
CY2024Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
34756 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
120609 usd
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
126607 usd
CY2024Q2 us-gaap Goodwill
Goodwill
7685636 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
25000 usd
CY2024Q2 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
58333 usd
CY2024Q3 us-gaap Loans Payable Current
LoansPayableCurrent
68269 usd
CY2024Q2 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
5764227 usd
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2024Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2024Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
162898727 usd
CY2024Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
162898727 usd
CY2024Q3 us-gaap Additional Paid In Capital Preferred Stock
AdditionalPaidInCapitalPreferredStock
1861142 usd
CY2024Q2 us-gaap Additional Paid In Capital Preferred Stock
AdditionalPaidInCapitalPreferredStock
1861142 usd
CY2024Q3 GTLL Exchange Shares To Be Issued
ExchangeSharesToBeIssued
1921409 usd
CY2024Q2 GTLL Exchange Shares To Be Issued
ExchangeSharesToBeIssued
1921409 usd
CY2024Q3 GTLL Common Stock To Be Issued Value
CommonStockToBeIssuedValue
30000 usd
CY2024Q2 GTLL Common Stock To Be Issued Value
CommonStockToBeIssuedValue
30000 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-166409747 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-166666296 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
1789020 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
1532471 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
8505716 usd
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
8362682 usd
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
669431 usd
CY2024Q3 us-gaap Cost Of Revenue
CostOfRevenue
191889 usd
CY2024Q3 us-gaap Gross Profit
GrossProfit
477542 usd
CY2024Q3 us-gaap Officers Compensation
OfficersCompensation
25000 usd
CY2023Q3 us-gaap Officers Compensation
OfficersCompensation
25000 usd
CY2024Q3 us-gaap Depreciation
Depreciation
5998 usd
CY2023Q3 us-gaap Depreciation
Depreciation
1298 usd
CY2023Q3 GTLL Consulting Services
ConsultingServices
250000 usd
CY2024Q3 us-gaap Professional Fees
ProfessionalFees
136916 usd
CY2024Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
42984 usd
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
48991 usd
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
210898 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
325289 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
266644 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-325289 usd
CY2023Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
1920292 usd
CY2024Q3 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
10095 usd
CY2023Q3 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
72099 usd
CY2023Q3 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
298082 usd
CY2024Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-10095 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1550111 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
256549 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1224822 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
256549 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
1224822 usd
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2024Q3 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
14688440097 shares
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14688440097 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
14539553430 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14539553430 shares
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-4528007 usd
CY2023Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
250000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
1224822 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-3053185 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
1532471 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
1532471 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
256549 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
256549 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
1789020 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
1789020 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
256549 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
1224822 usd
CY2023Q3 us-gaap Amortization Of Acquisition Costs
AmortizationOfAcquisitionCosts
25000 usd
CY2023Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
1920292 usd
CY2024Q3 us-gaap Depreciation
Depreciation
5998 usd
CY2023Q3 us-gaap Depreciation
Depreciation
1298 usd
CY2023Q3 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
250000 usd
CY2023Q3 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
298082 usd
CY2024Q3 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-28082 usd
CY2024Q3 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-40437 usd
CY2023Q3 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-21234 usd
CY2024Q3 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
10095 usd
CY2023Q3 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
27098 usd
CY2024Q3 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-43173 usd
CY2023Q3 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
12500 usd
CY2024Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
217114 usd
CY2023Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-102726 usd
CY2024Q3 GTLL Payments On Convertible Notes Payable
PaymentsOnConvertibleNotesPayable
-40000 usd
CY2023Q3 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
77616 usd
CY2023Q3 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
20000 usd
CY2024Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-40000 usd
CY2023Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
97616 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
177114 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-5110 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
115747 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
18300 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
292861 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
13190 usd
CY2023Q3 GTLL Accrual For Contingent Consideration Of Acquisition Of Foxx Trott Tango Llc
AccrualForContingentConsiderationOfAcquisitionOfFoxxTrottTangoLlc
3400000 usd
CY2024Q3 us-gaap Basis Of Accounting
BasisOfAccounting
<p id="xdx_800_eus-gaap--BasisOfAccounting_zh954l0nFIG8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE B – <span id="xdx_82C_zEHIPbiACtu9">BASIS OF PRESENTATION</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial statements and with Form 10-Q and Article 10 of Regulation S-X of the United States Securities and Exchange Commission (the “SEC”). Accordingly, they do not contain all information and footnotes required by GAAP for annual financial statements. The condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation. In the opinion of the Company’s management, the accompanying unaudited condensed consolidated financial statements contain all the adjustments necessary (consisting only of normal recurring accruals) to present the financial position of the Company as of September 30, 2024 and the results of operations, changes in stockholders’ equity, and cash flows for the periods presented. The results of operations for the three months ended September 30, 2024 are not necessarily indicative of the operating results for the full fiscal year or any future period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and related notes thereto included in the Company’s Annual Report on Form 10-K for the year ended June 30, 2024 as filed with the Securities and Exchange Commission on September 25, 2024. The Company’s accounting policies are described in the Notes to Consolidated Financial Statements in its Annual Report on Form 10-K for the year ended June 30, 2024, and updated, as necessary, in this Quarterly Report on Form 10-Q.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 usd
CY2024Q3 us-gaap Cash
Cash
292861 usd
CY2024Q3 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
42861 usd
CY2024Q3 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_84B_eus-gaap--ConcentrationRiskCreditRisk_zaaXfFAYUU4c" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_866_z7XT27f3Ywik">Concentrations of Risks</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; background-color: white"><i><span style="text-decoration: underline">Concentration of Accounts Receivable</span></i> – On September 30, 2024 and June 30, 2024, the Company had $<span id="xdx_909_eus-gaap--AccountsAndOtherReceivablesNetCurrent_iI_c20240930_zQ9o6Zd8YFX9" title="Accounts receivables">156,610</span> and $<span id="xdx_90D_eus-gaap--AccountsAndOtherReceivablesNetCurrent_iI_c20240630_zWTHeud49bxf" title="Accounts receivables">184,692</span> in accounts receivable, respectively. All of the accounts receivable at September 30, 2024 was from one supplier.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><i><span style="text-decoration: underline">Concentration of Revenues</span></i> – For the three months ended September 30, 2024 and 2023, the Company generated revenue of $<span id="xdx_900_eus-gaap--Revenues_c20240701__20240930_zUw5nXxWz3pc" title="Revenues">669,431</span> and $<span id="xdx_909_eus-gaap--Revenues_c20230701__20230930_z9ZbYlP4Zq27" title="Revenues"><span style="-sec-ix-hidden: xdx2ixbrl0536">-</span></span>, respectively. The Company’s revenue for the three months ended September 30, 2024 was largely attributable to revenue generated through 10 Fold Services.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><i><span style="text-decoration: underline">Concentration of Suppliers</span></i> – For the three months ended September 30, 2024 and 2023, the Company had <span id="xdx_901_eus-gaap--PaymentsToSuppliers_c20240701__20240930_zH59w6O6KVlc" title="Payments to suppliers">2</span> and <span id="xdx_90E_eus-gaap--PaymentsToSuppliers_c20230701__20230930_zV5aqvwsIO59" title="Payments to suppliers">0</span> suppliers, respectively. The two suppliers, pharmaceutical compounding companies, are for the sales generated through 10 Fold Services.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q3 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
156610 usd
CY2024Q2 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
184692 usd
CY2024Q3 us-gaap Revenues
Revenues
669431 usd
CY2024Q3 us-gaap Payments To Suppliers
PaymentsToSuppliers
2 usd
CY2023Q3 us-gaap Payments To Suppliers
PaymentsToSuppliers
0 usd
CY2024Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3000000000 shares
CY2023Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
29100000000 shares
CY2024Q3 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_848_eus-gaap--UseOfEstimates_ziGivDB5lgr6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_867_zJ1hc78nMor7">Use of Estimates</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenue and expenses during the reporting periods. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q3 us-gaap Business Combination Consideration Transferred Liabilities Incurred
BusinessCombinationConsiderationTransferredLiabilitiesIncurred
5764227 usd
CY2024Q3 us-gaap Accounts Receivable Gross
AccountsReceivableGross
156610 usd
CY2024Q2 us-gaap Accounts Receivable Gross
AccountsReceivableGross
184692 usd
CY2024Q3 us-gaap Accounts Receivable Net
AccountsReceivableNet
156610 usd
CY2024Q2 us-gaap Accounts Receivable Net
AccountsReceivableNet
184692 usd
CY2024Q3 GTLL Prepaid Deposits
PrepaidDeposits
225000 usd
CY2024Q2 GTLL Prepaid Deposits
PrepaidDeposits
225000 usd
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
225000 usd
CY2024Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
225000 usd
CY2024Q3 us-gaap Property Plant And Equipment Other
PropertyPlantAndEquipmentOther
36363 usd
CY2024Q2 us-gaap Property Plant And Equipment Other
PropertyPlantAndEquipmentOther
36363 usd
CY2024Q3 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
125000 usd
CY2024Q2 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
125000 usd
CY2024Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
161363 usd
CY2024Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
161363 usd
CY2024Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
40754 usd
CY2024Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
34756 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
120609 usd
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
126607 usd
CY2024Q3 us-gaap Depreciation
Depreciation
5998 usd
CY2023Q3 us-gaap Depreciation
Depreciation
1298 usd
CY2024Q3 us-gaap Loans Payable Current
LoansPayableCurrent
68269 usd
CY2024Q2 us-gaap Loans Payable Current
LoansPayableCurrent
68269 usd
CY2024Q3 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
327947 usd
CY2024Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
327947 usd
CY2024Q3 GTLL Preferred Stock Rank Description
PreferredStockRankDescription
All shares of the Series K Super Voting Preferred Stock shall rank (i) senior to the Corporation’s (A) Common Stock, par value $0.0001 per share (“Common Stock”), and any other class or series of capital stock of the Corporation hereafter created, except as otherwise provided in clauses (ii) and (iii) of this Section 4, (ii) pari passu with any class or series of capital stock of the Corporation hereafter created and specifically ranking, by its terms, on par with the Series K Super Voting Preferred-Stock and (iii) junior to any class or series of capital stock of the Corporation hereafter created specifically ranking, by its terms, senior to the Series K Preferred Stock, in each case as to distribution of assets upon liquidation, dissolution or winding up of the Corporation, whether voluntary or involuntary
CY2024Q3 us-gaap Common Stock Voting Rights
CommonStockVotingRights
The holders of the Class A Shares and the Class B Shares shall vote as a single class on all matters submitted to a vote of the stockholders, with each Class A Share being entitled to one (1) vote and each Class B Share being entitled to six (6) votes, except as otherwise provided by law
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-166409747 usd
CY2024Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
217114 usd
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001493152-24-044515-index-headers.html Edgar Link pending
0001493152-24-044515-index.html Edgar Link pending
0001493152-24-044515.txt Edgar Link pending
0001493152-24-044515-xbrl.zip Edgar Link pending
ex21-1.htm Edgar Link pending
ex21-1_001.jpg Edgar Link pending
ex21-1_002.jpg Edgar Link pending
ex21-1_003.jpg Edgar Link pending
ex21-1_004.jpg Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
gtll-20240930.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
gtll-20240930_cal.xml Edgar Link unprocessable
gtll-20240930_def.xml Edgar Link unprocessable
gtll-20240930_pre.xml Edgar Link unprocessable
gtll-20240930_lab.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable